New oral anticoagulants and hepatocellular carcinoma among patients with HBV, HCV, and alcoholic liver diseases: a nationwide cohort study
{{output}}
Background: Coagulation pathways are increasingly recognized as an influencer of tumor development. Experimental evidence suggests that commonly used anticoagulants, including warfarin and non-vitamin K oral anticoagulants (NOACs... ...
